The PROPKD Score: A New Algorithm to Predict Renal Survival in Autosomal Dominant Polycystic Kidney Disease.

@article{Gall2016ThePS,
  title={The PROPKD Score: A New Algorithm to Predict Renal Survival in Autosomal Dominant Polycystic Kidney Disease.},
  author={Emilie Cornec-Le Gall and M. Audr{\'e}zet and Annick Rousseau and Nasrollah Ghahramani and Eric Renaudineau and Christophe Charasse and M. Morin and Marie-Christine Moal and Jacques Dantal and Bassem Wehbe and R{\'e}gine Perrichot and Thierry Frouget and C{\'e}cile Vigneau and J{\'e}r{\^o}me Potier and Philippe Jousset and M. Guillodo and Pascale Siohan and Nazim Terki and Th{\'e}ophile Sawadogo and Didier Legrand and Victorio Menoyo-Calonge and Seddik Benarbia and Dominique Besnier and H{\'e}l{\`e}ne Longuet and Greg Conf. Sec. Smith and Yannick Le Meur},
  journal={Journal of the American Society of Nephrology : JASN},
  year={2016},
  volume={27 3},
  pages={
          942-51
        }
}
The course of autosomal dominant polycystic kidney disease (ADPKD) varies among individuals, with some reaching ESRD before 40 years of age and others never requiring RRT. In this study, we developed a prognostic model to predict renal outcomes in patients with ADPKD on the basis of genetic and clinical data. We conducted a cross-sectional study of 1341 patients from the Genkyst cohort and evaluated the influence of clinical and genetic factors on renal survival. Multivariate survival analysis… CONTINUE READING

Similar Papers

Citations

Publications citing this paper.
SHOWING 1-10 OF 44 CITATIONS

Can we further enrich autosomal dominant polycystic kidney disease clinical trials for rapidly progressive patients? Application of the PROPKD score in the TEMPO trial

  • Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association
  • 2018
VIEW 9 EXCERPTS
CITES BACKGROUND & RESULTS
HIGHLY INFLUENCED

Antenatally Diagnosed ADPKD

  • Kidney international reports
  • 2018
VIEW 4 EXCERPTS
CITES BACKGROUND
HIGHLY INFLUENCED

Management of autosomal-dominant polycystic kidney disease—state-of-the-art

  • Clinical kidney journal
  • 2018
VIEW 3 EXCERPTS
CITES BACKGROUND
HIGHLY INFLUENCED

Recommendations for the use of tolvaptan in autosomal dominant polycystic kidney disease: a position statement on behalf of the ERA-EDTA Working Groups on Inherited Kidney Disorders and European Renal Best Practice

  • Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association
  • 2016
VIEW 3 EXCERPTS
CITES BACKGROUND
HIGHLY INFLUENCED

References

Publications referenced by this paper.
SHOWING 1-10 OF 28 REFERENCES

Epidemiology of patients in England and Wales with autosomal dominant polycystic kidney disease and end-stage renal failure.

  • Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association
  • 2014

ALADIN study group: Effect of longacting somatostatin analogue on kidney and cyst growth in autosomal dominant polycystic kidney disease (ALADIN): a randomised, placebo-controlled, multicentre trial

A Caroli, N Perico, +18 authors P Ruggenenti
  • 2013

Effect of longacting somatostatin analogue on kidney and cyst growth in autosomal dominant polycystic kidney disease ( ALADIN ) : a randomised , placebo - controlled , multicentre trial

A Caroli, N Perico, +17 authors P Ruggenenti
  • Lancet
  • 2013

Type of PKD1 mutation influences renal outcome in ADPKD.

  • Journal of the American Society of Nephrology : JASN
  • 2013